Anergis Files Provisional U.S. Patent on AllerDM Dust Mite Allergy Treatment
6/13/2013 9:01:20 AM
More...
|
Anergis Presents Preclinical Data of its Ragweed Allergy Vaccine Candidate AllerR
2/21/2013 10:33:11 AM
More...
|
Anergis Expands Management Team
2/14/2013 10:22:56 AM
More...
|
Anergis Obtains U.S. Patent for Lead Product AllerT
1/23/2013 11:00:04 AM
More...
|
Anergis Starts European Phase IIb Clinical Trial With AllerT in Patients With Moderate to Severe Allergy to Birch Pollen
11/6/2012 9:30:04 AM
More...
|